Immediate Impact

2 by Nobel laureates 1 from Science/Nature 61 standout
Sub-graph 1 of 23

Citing Papers

In situ targeted base editing of bacteria in the mouse gut
2024 StandoutNature
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
2024 Standout
5 intermediate papers

Works of Pei An being referenced

Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2)
2023
Abstract 10111: Efficacy and Safety of Tafolecimab in Chinese Patients With Non-Familial Hypercholesterolemia (CREDIT-1): A 48-Week Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
2022
and 3 more

Author Peers

Author Last Decade Papers Cites
Pei An 219 350 77 279 33 794
Jing Feng 189 118 167 71 42 803
Elizabeth M. Gordon 234 108 184 70 34 943
Adriana Bosco 230 106 11 104 42 792
Meiyan Jiang 167 121 35 49 23 650
Przemysław Kaczmarek 199 83 144 49 48 869
Ahmed A. Rahman 196 101 55 70 45 737
Alok De 177 228 8 116 29 748
Jing Zhang 142 96 43 36 41 698
Nicholas J. Hunt 165 123 17 75 24 650
Richard Wagner 210 150 30 61 22 696

All Works

Loading papers...

Rankless by CCL
2026